Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Área temáticas
Enfermedades(3)
Farmacología y terapéutica(1)
Medicina forense; incidencia de enfermedades(1)
Problemas sociales y servicios a grupos(1)
Origen
scopus(3)
Clinical and epidemiological features of leishmaniasis in northwestern-Argentina through a retrospective analysis of recent cases
ArticleAbstract: Leishmaniasis is a parasitic disease caused by hemoflagellates of the genus Leishmania and is transmPalabras claves:Cutaneous leishmaniasis, Leishmania (L.) amazonensis, Leishmania (L.) infantum, Leishmania (V.) braziliensis, Mucocutaneous leishmaniasis, Visceral leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., Beckar J., Fabricio Miguel Locatelli, González-Prieto G., Hashiguchi Y., Jaime D., Jorge Diego Marco, María Celia Mora, María Fernanda García Bustos, Monroig S., Moreno S., Parodi C.M., Ramos F., Sajama J., Yeo M.Fuentes:scopusB-cell profile, B-cell activating factor concentration and IgG levels in human cutaneous and mucosal leishmaniasis
ArticleAbstract: Aims: The aim of this study was to evaluate characteristics of B cells in human tegumentary leismaniPalabras claves:B lymphocytes, B-cell activating factor, Cutaneous leishmaniasis, hypergammaglobulinemia, interferon-gamma, Interleukin-6, Mucocutaneous leishmaniasisAutores:Albareda M.C., Alejandra Beatriz Barrio, Badano N., Castro Eiro M.E., de Elizalde de Bracco M.M., González Prieto A.G., Laucella S.A., María Fernanda García Bustos, Parodi C.M., Pimentel J.Fuentes:scopusMiltefosine versus meglumine antimoniate in the treatment of mucosal leishmaniasis
ArticleAbstract: The conventional treatment for tegumentary leishmaniasis is meglumine antimoniate, which needs parenPalabras claves:Leishmaniasis treatment, Miltefosine, Mucocutaneous leishmaniasisAutores:Alejandra Beatriz Barrio, Basombŕo M.A., Beckar J., María Fernanda García Bustos, Moreno S., Parodi C.M.Fuentes:scopus